Corporate Compliance

CMS, NCI to bring new drugs, better treatment to cancer patients

Compliance Monitor, June 9, 2004

Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!

CMS and the National Cancer Institute (NCI) announced June 7 they will join forces to bring new anti-cancer drugs to patients.

Collaborative efforts will increase the body of information that clinicians and patients use to guide decisions about how providers can use new technologies more effectively to improve the lives of cancer patients, according to a CMS press release.

"With so many new therapeutic options available to patients and doctors, and with patients becoming more active in their medical care, it's important that we make sure that they have relevant and reliable information to support the choices they're making," said CMS Administrator Mark McClellan, MD, PhD. "Setting proper priorities for clinical research-and finding more ways to support the critical clinical research studies-is an important priority for us."

To read more, click here.



Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!

    Strategies for Health Care Compliance
  • Strategies for Health Care Compliance

    News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...

  • Compliance Monitor

    This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...

  • Medicare Weekly Update

    Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...

  • Medicare Update for Physician Services

    Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...

Most Popular

Related Articles